Search NovaTechs

NovaSeal®
Interventional Radiology
Clinical Trials
Embolization

Our Products

Revolutionary embolic solutions for interventional radiology

Current Solutions

NovaSeal® - Our flagship product

NovaSeal Product
Ready-to-use Bio-based Non-toxic

NovaSeal®

Innovative Liquid Embolic Agent

NovaSeal® is packaged as a ready-to-use product, eliminating the need for complex and time-consuming preparation steps in hospitals. The injection is painless, addressing the significant pain that often requires patients to undergo anesthesia with other products.

Unlike marketed products that rely on heavy metals like tantalum, which pose toxicity risks, NovaSeal® provides a safer alternative. By avoiding toxic solvents and enhancing ease of use, NovaSeal® significantly improves the experience for both patients and healthcare providers.

Ready-to-use

No complex preparation required

Painless

No anesthesia required

Non-toxic

No heavy metals or toxic solvents

Product Specifications

Comprehensive features and benefits of NovaSeal®

Localized Delivery

The unique technique allows for the targeted application of embolic agents directly to the tumor site, minimizing systemic exposure and reducing side effects on healthy tissues.

Tumor Penetration

Our pioneering approach ensures precise penetration, effectively disrupting the blood supply to hypervascular tumors, enabling embolic gels to starve the cancer cells of oxygen and nutrients.

Minimally Invasive

Providing a minimally invasive alternative to surgery reduces recovery times, minimizes surgery-related complications, improves patient outcomes, and enhances healthcare efficiency.

Embolization Precision

Leveraging advanced technologies and meticulous design, we prevent unintended embolization, enhancing precision in treating hypervascular tumors.

Biocompatible & Biodegradable

Composed of biocompatible and biodegradable polymers ensures safety and minimizes long-term foreign body reactions in clinical applications.

Less-toxic Formulations

By eliminating toxic materials like DMSO and tantalum, NovaSeal® minimizes environmental impact, contributing to the sustainability of medical products and aligning with global ecological goals.

Efficient Formulations

Our formulations and preparations are meticulously engineered for optimal efficiency, streamlining procedures and enhancing treatment outcomes for hypervascular tumors.

Simplified Procedures

Prioritizing user-friendly design and developing technologies that simplify procedural complexities, we make embolization treatments for hypervascular tumors more accessible and efficient.

Real-time Monitoring

Using a contrast agent and imaging techniques during and after the procedure allows for real-time monitoring of the treatment's effectiveness and adjustment of strategies if needed.

Pipeline Products

Upcoming products and progress updates

Future Development

Our research and development team is continuously working on next-generation embolic solutions that will expand our treatment capabilities and improve patient outcomes across a broader range of conditions.

We are currently in the early stages of developing advanced formulations and exploring new applications for our gel-based technology platform.

Research Phase

Laboratory research and formulation development

Preclinical Studies

In vitro and in vivo validation

Clinical Trials

Human safety and efficacy studies

Pipeline Development
Advanced Formulations
Extended Applications
Improved Efficacy

Why Choose NovaSeal®?

Comparison with traditional embolic agents

Feature
NovaSeal®
Traditional Agents
Preparation Time
Ready-to-use
Complex preparation
Patient Comfort
Painless procedure
Often requires anesthesia
Toxicity
Non-toxic materials
Heavy metals (tantalum)
Environmental Impact
Bio-based & sustainable
Toxic solvents (DMSO)
Monitoring
Real-time imaging
Limited visibility
Precision
High precision delivery
Risk of unintended embolization